Low-Dose Clozapine in Schizophrenia With Aggression After a Single Failed Antipsychotic Trial

References (12)

1. Hany M, Rehman B, Rizvi A, et al. Schizophrenia. In: StatPearls [Internet]. StatPearls Publishing; 2024. https://www.ncbi.nlm.nih.gov/books/NBK539864/
2. Keepers GA, Fochtmann LJ, Anzia JM, et al. The American Psychiatric Association practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 2020;177(9):868–872. CrossRef
3. Agid O, Arenovich T, Sajeev G, et al. An algorithm-based approach to first-episode schizophrenia: response rates over 3 prospective antipsychotic trials with a retrospective data analysis. J Clin Psychiatry. 2011;72(11):1439–1444. PubMed CrossRef
4. Remington G, Agid O, Foussias G, et al. Clozapine’s role in the treatment of first-episode schizophrenia. Am J Psychiatry. 2013;170(2):146–151. PubMed CrossRef
5. Varghese MT, Jyothi KS, Shaji KS, et al. Delaying clozapine: how long is too long? Gen Psychiatr. 2020;33(2):e100172. PubMed
6. Taipale H, Tanskanen A, Mehtälä J, et al. 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry. 2020;19(1):61–68. PubMed CrossRef
7. Lieberman JA, Safferman AZ, Pollack S, et al. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry. 1994;151(12):1744–1752. PubMed CrossRef
8. Carranza Navarro F, Álvarez Villalobos NA, Contreras Muñoz AM, et al. Predictors of the length of stay of psychiatric inpatients: protocol for a systematic review and meta-analysis. Syst Rev. 2021;10(1):65. PubMed CrossRef
9. Rizvi A, Reyazuddin M, Shaan F. Low-dose clozapine in early-onset resistant schizophrenia: case report and 2-year follow-up. J Am Acad Child Adolesc Psychiatry. 2023;62(8):839–841. PubMed CrossRef
10. Subramanian S, Völlm BA, Huband N. Clozapine dose for schizophrenia. Cochrane Database Syst Rev. 2017;6(6):CD009555. PubMed CrossRef
11. Siskind D, Sharma M, Pawar M, et al. Clozapine levels as a predictor for therapeutic response: a systematic review and meta-analysis. Acta Psychiatr Scand. 2021;144(5):422–432. PubMed CrossRef
12. partanen JJ, Häppölä P, Kämpe A, et al. High burden of ileus and pneumonia in clozapine-treated individuals with schizophrenia: a Finnish 25-year follow-up register study. Am J Psychiatry. 2024;181(10):879–892. PubMed CrossRef